Risankizumab

Educational summary, not a formulary. Dosing is quoted from the Makindo chapters and topics site. The other sections are draft summaries not yet checked line by line against the BNF or SPC. Check dose, indication, interactions and monitoring in the BNF entry for Risankizumab and local guidelines before prescribing.

Biologic (IL-23)

Mechanism

IL-23 p19 monoclonal antibody.

Uses

Plaque psoriasis, psoriatic arthritis, Crohn disease.

Dosing

No dose is given in the chapters. See the BNF.

Side effects

Upper respiratory infection, headache, injection-site reaction.

Interactions

Live vaccines contraindicated.

Contraindications and cautions

Active TB

Monitoring

Infection, LFT in Crohn disease

Pregnancy and breastfeeding

Avoid

Renal and hepatic impairment

No adjustment

Overdose and reversal

Supportive

Special advice

Screen for TB and hepatitis.

More from the textbook: uses, cautions and other points
Where it is discussed in the book